Cargando…
The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
Autores principales: | Zgliczyński, Wojciech, Zdunowski, Piotr, Czajka-Oraniec, Izabella, Jeske, Wojciech, Zieliński, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618015/ http://dx.doi.org/10.1186/1756-6614-6-S2-A64 |
Ejemplares similares
-
Real-World Experience With Pasireotide Lar in Acromegaly Resistant to First-Generation Somatostatin Analogs: A Single Center 1-Year Observation
por: Stelmachowska-Banas, Maria, et al.
Publicado: (2021) -
Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022) -
The influence of growth hormone deficiency on bone health and metabolisms
por: Wydra, Arnika, et al.
Publicado: (2023) -
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation
por: Stelmachowska-Banaś, Maria, et al.
Publicado: (2021) -
Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospective single center study
por: Popielarz-Grygalewicz, Agata, et al.
Publicado: (2023)